Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Focused ultrasound tissue ablation is a non-invasive therapeutic procedure using concentrated ultrasound energy to heat and destroy targeted tissue volumes by inducing rapid cell death primarily via thermal coagulation and, in certain modalities, mechanical disruption (cavitation/histotripsy)[1][2][3][4][5][6]. It is used across numerous clinical indications such as tumor ablation, pain management, and neurological disorder treatment[1][2][3]. Unlike conventional molecular targets (receptors, enzymes, etc.), tissue ablation by focused ultrasound is a procedural approach rather than a discrete molecular entity. Monitoring technologies like MRI are employed for real-time guidance and safety[1][3][6].
Thermal energy ablation: raising tissue temperature above ~55°C causes coagulative necrosis and cell death[1][2][3][6] Mechanical disruption: Cavitation and acoustic phenomena can physically disrupt tissue (e.g., “histotripsy”)[2][3][5] Increased permeability: Temporary opening of blood-brain barrier or cell membranes to facilitate drug delivery (adjunct mechanism)[3][4] Non-invasive; precise localization protects adjacent healthy tissue[1][3][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue ablation by focused ultrasound.